<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK26373" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK26373/" /><meta name="ncbi_pagename" content="MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/04/11" /><meta name="citation_author" content="Alexandra M Dumitrescu" /><meta name="citation_author" content="Jiao Fu" /><meta name="citation_author" content="Melissa A Dempsey" /><meta name="citation_author" content="Samuel Refetoff" /><meta name="citation_pmid" content="20301789" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK26373/" /><meta name="citation_keywords" content="Allan-Herndon-Dudley Syndrome" /><meta name="citation_keywords" content="Allan-Herndon-Dudley Syndrome" /><meta name="citation_keywords" content="Monocarboxylate transporter 8" /><meta name="citation_keywords" content="SLC16A2" /><meta name="citation_keywords" content="MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Alexandra M Dumitrescu" /><meta name="DC.Contributor" content="Jiao Fu" /><meta name="DC.Contributor" content="Melissa A Dempsey" /><meta name="DC.Contributor" content="Samuel Refetoff" /><meta name="DC.Date" content="2013/04/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK26373/" /><meta name="description" content="MCT8-specific thyroid hormone cell-membrane transporter deficiency is characterized by severe cognitive deficiency, infantile hypotonia, diminished muscle mass and generalized muscle weakness, progressive spastic quadriplegia, joint contractures, and dystonic and/or athetoid movement with characteristic paroxysms or kinesigenic dyskinesias. Seizures occur in about 25% of cases. Most affected males never sit or walk independently or lose these abilities over time; most never speak or have severely dysarthric speech. Brain MRI obtained in the first few years of life shows transient delayed myelination, which improves by age four years. Although psychomotor findings observed in affected males do not occur in heterozygous females, the latter often have thyroid test abnormalities intermediate between affected and normal individuals." /><meta name="og:title" content="MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="MCT8-specific thyroid hormone cell-membrane transporter deficiency is characterized by severe cognitive deficiency, infantile hypotonia, diminished muscle mass and generalized muscle weakness, progressive spastic quadriplegia, joint contractures, and dystonic and/or athetoid movement with characteristic paroxysms or kinesigenic dyskinesias. Seizures occur in about 25% of cases. Most affected males never sit or walk independently or lose these abilities over time; most never speak or have severely dysarthric speech. Brain MRI obtained in the first few years of life shows transient delayed myelination, which improves by age four years. Although psychomotor findings observed in affected males do not occur in heterozygous females, the latter often have thyroid test abnormalities intermediate between affected and normal individuals." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK26373/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/thctd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK26373/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88122CE04105A100000000034A0147.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK26373_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK26373_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mbd5-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rett/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK26373_"><span class="title" itemprop="name">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Allan-Herndon-Dudley Syndrome</div><p class="contrib-group"><span itemprop="author">Alexandra M Dumitrescu</span>, MD, PhD, <span itemprop="author">Jiao Fu</span>, MD, <span itemprop="author">Melissa A Dempsey</span>, MS, and <span itemprop="author">Samuel Refetoff</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK26373_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK26373_ai__"><div class="contrib half_rhythm"><span itemprop="author">Alexandra M Dumitrescu</span>, MD, PhD<div class="affiliation small">Assistant Professor, University of Chicago Medical Center<br />Chicago, Illinois<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ogacihcu@dxela" class="oemail">ude.ogacihcu@dxela</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jiao Fu</span>, MD<div class="affiliation small">Visiting Graduate Student, University of Chicago Medical Center<br />Chicago, Illinois<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ogacihcu@zyxoaijuf" class="oemail">ude.ogacihcu@zyxoaijuf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Melissa A Dempsey</span>, MS<div class="affiliation small">Certified Genetic Counselor, Parkview Health<br />Fort Wayne, Indiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@32yespmedlem" class="oemail">moc.liamg@32yespmedlem</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Samuel Refetoff</span>, MD<div class="affiliation small">Professor of Medicine, Pediatrics &#x00026; Genetics<br />University of Chicago Medical Center<br />Chicago, Illinois<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ogacihcu@ffotefer" class="oemail">ude.ogacihcu@ffotefer</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">March 9, 2010</span>; Last Update: <span itemprop="dateModified">April 11, 2013</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="thctd.Summary" itemprop="description"><h2 id="_thctd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency is characterized by severe cognitive deficiency, infantile hypotonia, diminished muscle mass and generalized muscle weakness, progressive spastic quadriplegia, joint contractures, and dystonic and/or athetoid movement with characteristic paroxysms or kinesigenic dyskinesias. Seizures occur in about 25% of cases. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males never sit or walk independently or lose these abilities over time; most never speak or have severely dysarthric speech. Brain MRI obtained in the first few years of life shows transient delayed myelination, which improves by age four years. Although psychomotor findings observed in affected males do not occur in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females, the latter often have thyroid test abnormalities intermediate between affected and normal individuals.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males tested to date have had pathognomonic thyroid test results including high serum 3,3',5-triiodothyronine (T<sub>3</sub> ) concentration and low serum 3,3',5'-triiodothyronine (reverse T<sub>3</sub> or rT<sub>3</sub>) concentration. Serum tetraiodothyronine (thyroxine or T<sub>4</sub>) concentration is often reduced, but may be within the low normal range; serum TSH concentrations are normal or slightly elevated. <i>SLC16A2</i> (also known as <i>MCT8</i>) is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause this disorder.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Physical, occupational, and speech therapies, if necessary. Anticholinergics, L-DOPA, carbamazepine, or lioresol for the treatment of dystonia. Glycopyrolate or scopolamine to reduce drooling. Standard antiepileptic drugs to control seizures, if present. Placement of permanent feeding tube to maintain caloric intake.</p><p><i>Prevention of secondary complications:</i> Braces to prevent joint contractures and orthopedic surgery, if necessary. Dietary restrictions to prevent aspiration.</p><p><i>Surveillance:</i> Regular orthopedic evaluations to monitor scoliosis or joint problems; ongoing developmental assessments.</p><p><i>Agents/circumstances to avoid</i>: Administration of L-T<sub>4</sub> or L-T<sub>3</sub> alone can exacerbate the high serum T<sub>3</sub> levels and the resulting hypermetabolism.</p><p><i>Other</i>: Thyroid hormone treatment, in replacement doses, during childhood has no beneficial effect. Combined treatment with high doses of levothyroxine (L-T<sub>4</sub>) and propylthiouracil (PTU), which inhibits deiodinase 1, has been shown to ameliorate the hypermetabolic state, with beneficial effects on body weight and heart rate. Similarly a thyromimetic compound diiodothyropropionic acid (DITPA) given to four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children improved the hypermetabolic state. However, both therapies resulted in no significant neurologic improvement.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. Women who are carriers have a 50% chance of transmitting the <i>SLC16A2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy. Male offspring who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female offspring who inherit the variant will be carriers and will usually not be affected although they may have minor thyroid test abnormalities. No affected male has reproduced. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant in the family is known.</p></div></div><div id="thctd.Diagnosis"><h2 id="_thctd_Diagnosis_">Diagnosis</h2><div id="thctd.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The features described in 100% of individuals with MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency are hypotonia and severe intellectual disability. Thus, the diagnosis should be suspected in males with at least two of the following:</p><ul><li class="half_rhythm"><div>Hypotonia/dystonia and feeding difficulties in the first months of life</div></li><li class="half_rhythm"><div>Truncal hypotonia</div></li><li class="half_rhythm"><div>Muscle hypoplasia/asthenic build</div></li><li class="half_rhythm"><div>Poor head control</div></li><li class="half_rhythm"><div>Spastic paraparesis with dystonic/athetoic movements (with extensor posturing mainly affecting the distal upper limbs)</div></li><li class="half_rhythm"><div>Paroxysmal dyskinesia</div></li><li class="half_rhythm"><div>Dysarthric or no speech</div></li><li class="half_rhythm"><div>Severe psychomotor retardation and cognitive impairment</div></li></ul><p>Other findings include poor weight gain, limb rigidity with contractures, brisk deep tendon reflexes, clonus, and seizures.</p><p>Brain MRI shows absent or markedly delayed myelination that may not be appreciated after age four years [<a class="bk_pop" href="#thctd.REF.holden.2005.852">Holden et al 2005</a>, <a class="bk_pop" href="#thctd.REF.kakinuma.2005.552">Kakinuma et al 2005</a>, <a class="bk_pop" href="#thctd.REF.sijens.2008.1854">Sijens et al 2008</a>, <a class="bk_pop" href="#thctd.REF.gika.2010.475">Gika et al 2010</a>, <a class="bk_pop" href="#thctd.REF.tsurusaki.2011.606">Tsurusaki et al 2011</a>, <a class="bk_pop" href="#thctd.REF.tonduti.2013.795">Tonduti et al 2013</a>]. Note: Early reports of normal MRI in this disorder were from older individuals.</p></div><div id="thctd.Testing"><h3>Testing</h3><p><b>Affected males</b>. See <a class="figpopup" href="/books/NBK26373/figure/thctd.F1/?report=objectonly" target="object" rid-figpopup="figthctdF1" rid-ob="figobthctdF1">Figure 1</a>. Males with MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency have pathognomonic thyroid test results including the following:</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figthctdF1" co-legend-rid="figlgndthctdF1"><a href="/books/NBK26373/figure/thctd.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figthctdF1" rid-ob="figobthctdF1"><img class="small-thumb" src="/books/NBK26373/bin/thctd-Image001.gif" src-large="/books/NBK26373/bin/thctd-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndthctdF1"><h4 id="thctd.F1"><a href="/books/NBK26373/figure/thctd.F1/?report=objectonly" target="object" rid-ob="figobthctdF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Thyroid function tests from six families with MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency studied at the University of Chicago &#x02022; 7 affected males (M, in red squares)</p></div></div><ul><li class="half_rhythm"><div class="half_rhythm">High serum 3,3&#x02019;,5-triiodothyronine (T<sub>3</sub> ) concentration and low serum 3,3&#x02019;,5&#x02019;-triiodothyronine (reverse T<sub>3</sub> or rT<sub>3</sub>) concentration</div><div class="half_rhythm">Note: All individuals with <i>SLC16A2</i> pathogenic variants had high serum T<sub>3</sub> concentration and, when obtained, low serum rT<sub>3</sub> concentration. This holds true for both total and free hormone concentrations in serum.</div></li><li class="half_rhythm"><div class="half_rhythm">Serum tetraiodothyronine (thyroxine or T<sub>4</sub>) concentration that is often reduced, but may be within the low normal range</div></li><li class="half_rhythm"><div class="half_rhythm">Serum TSH concentrations that are normal or slightly elevated (<a class="figpopup" href="/books/NBK26373/figure/thctd.F1/?report=objectonly" target="object" rid-figpopup="figthctdF1" rid-ob="figobthctdF1">Figure 1</a>) [<a class="bk_pop" href="#thctd.REF.refetoff.2007.277">Refetoff &#x00026; Dumitrescu 2007</a>, <a class="bk_pop" href="#thctd.REF.dumitrescu.2009">Dumitrescu &#x00026; Refetoff 2009</a>]</div></li></ul><p><b>Carrier females</b>. Thyroid hormone concentrations in female carriers are intermediate between <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males and unaffected family members (<a class="figpopup" href="/books/NBK26373/figure/thctd.F1/?report=objectonly" target="object" rid-figpopup="figthctdF1" rid-ob="figobthctdF1">Figure 1</a>) [<a class="bk_pop" href="#thctd.REF.refetoff.2007.277">Refetoff &#x00026; Dumitrescu 2007</a>, <a class="bk_pop" href="#thctd.REF.dumitrescu.2009">Dumitrescu &#x00026; Refetoff 2009</a>]. However, results of thyroid tests in females cannot be reliably used to identify <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females; carrier status determination requires <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><div id="thctd.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>SLC16A2</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause MCT8-specific thyroid hormone cell-membrane transporter deficiency.</p><div id="thctd.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK26373/table/thctd.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__thctd.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_2" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_3" style="text-align:left;vertical-align:middle;">Allelic Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th></tr><tr><th headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_4" id="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Affected Males</th><th headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_4" id="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carrier Females&#x000a0;<sup>4</sup></th></tr></thead><tbody><tr><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC16A2</i></td><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_4 hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_4 hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>8</sup></td><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(Multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_4 hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>9</sup></td><td headers="hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_1_4 hd_h_thctd.T.molecular_genetic_testing_used_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="thctd.TF.1.1"><p class="no_margin">See <a href="/books/NBK26373/#thctd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="thctd.TF.1.2"><p class="no_margin">See <a href="#thctd.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="thctd.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="thctd.TF.1.4"><p class="no_margin">When no <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males in the family are available for testing</p></div></dd><dt>5. </dt><dd><div id="thctd.TF.1.5"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>6. </dt><dd><div id="thctd.TF.1.6"><p class="no_margin">Sequence analysis of <i>SLC16A2</i> is expected to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with the typical thyroid test results; however, the exact variant detection rate is unknown.</p></div></dd><dt>7. </dt><dd><div id="thctd.TF.1.7"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA cannot detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female.</p></div></dd><dt>8. </dt><dd><div id="thctd.TF.1.8"><p class="no_margin">Testing that identifies deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA; included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>9. </dt><dd><div id="thctd.TF.1.9"><p class="no_margin">Exon and multiexon deletions have been reported but the frequency is unknown [<a class="bk_pop" href="#thctd.REF.vaursbarri_re.2009.114">Vaurs-Barri&#x000e8;re et al 2009</a>, <a class="bk_pop" href="#thctd.REF.visser.2009.29">Visser et al 2009</a>].</p></div></dd></dl></div></div></div></div></div><div id="thctd.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency can be established in a male with psychomotor delays and the characteristic thyroid test results.</p><ul><li class="half_rhythm"><div>To date, no persons with <i>SLC16A2</i> pathogenic variants have been reported with normal or non-characteristic thyroid test results; thus, it is recommended that thyroid testing (including T<sub>3</sub> and rT<sub>3</sub> concentrations) be performed first.</div></li><li class="half_rhythm"><div>The diagnosis is confirmed when a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is identified in <i>SLC16A2</i> through <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, respectively.</div></li></ul><p><b>Carrier testing for at-risk female relatives</b> can be done either (a) after prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family or, (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is not available for thyroid hormone testing, by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. If no pathogenic variant is identified, other methods to detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> abnormalities can be used.</p><p>Note: Carrier females are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder and usually do not develop clinical findings related to the disorder.</p></div></div><div id="thctd.Clinical_Characteristics"><h2 id="_thctd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="thctd.Clinical_Description"><h3>Clinical Description</h3><p><b>Neonatal period.</b> Infants with MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency have normal length, weight, and head circumference measurements at birth. Hypotonia and feeding difficulties can appear in the first weeks or months of life.</p><p><b>Growth.</b> Linear growth is typically normal, but approximately 20% of males have short stature [<a class="bk_pop" href="#thctd.REF.schwartz.2007.307">Schwartz &#x00026; Stevenson 2007</a>]. Weight gain lags behind linear growth; microcephaly becomes apparent with advancing age.</p><p><b>Craniofacial.</b> Common facial findings that may be attributed to prenatal and infantile hypotonia include ptosis, open mouth, and a tented upper lip. Ear length is above the 97<sup>th</sup> centile in about half of adults. Cup-shaped ears, thickening of the nose and ears, upturned earlobes, and a decrease in facial creases are also reported.</p><p><b>Neuromuscular.</b> Truncal hypotonia persists into adulthood. Progressive hypertonicity of the limbs leads to spastic quadriplegia and joint contractures. Overall, muscle mass is diminished and associated with generalized muscle weakness. Affected males are described with "limber neck" or poor head control even as adults.</p><p>It is common for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males to experience purposeless movements described as dystonic and/or athetoid and characteristic paroxysms or kinesigenic dyskinesias [<a class="bk_pop" href="#thctd.REF.brockmann.2005.663">Brockmann et al 2005</a>, <a class="bk_pop" href="#thctd.REF.fuchs.2009.240">Fuchs et al 2009</a>]. These can be triggered by somatosensory stimuli, including changing clothes or lifting the affected child. During attacks, the body extends and the mouth opens; stretching or flexing of the limbs lasts as long as one to two minutes.</p><p>Seizures occur in approximately 25% of individuals with onset during infancy or early childhood [<a class="bk_pop" href="#thctd.REF.schwartz.2007.307">Schwartz &#x00026; Stevenson 2007</a>].</p><p>Brisk reflexes, ankle clonus, and extensor plantar responses (Babinski sign) are common. Rotary nystagmus and disconjugate eye movements have been reported but are not common [<a class="bk_pop" href="#thctd.REF.dumitrescu.2004.168">Dumitrescu et al 2004</a>].</p><p><b>Skeletal.</b> Pectus excavatum and scoliosis are common, most likely the result of hypotonia and reduced muscle mass.</p><p><b>Behavior.</b> Generally, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are attentive, friendly, and docile. They are not aggressive or destructive.</p><p><b>Development.</b> Psychomotor retardation is observed in 100% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males. Most affected males either never sit or walk independently or lose these abilities over time. In addition, most affected males never speak or may develop only garbled sounds secondary to severely dysarthric speech.</p><p><b>Other</b>. Findings typical of hypothyroidism in infancy (i.e., prolonged neonatal jaundice, myxedematous skin changes, macroglossia, hoarseness, umbilical hernias, and short stature) are absent [<a class="bk_pop" href="#thctd.REF.schwartz.2005.41">Schwartz et al 2005</a>].</p><p><b>Life span.</b> Early death has occurred in some individuals, usually caused by recurrent infections and/or aspiration pneumonia. In a few instances survival beyond age 70 years has been reported.</p><p><b>Affected <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females.</b> A female with typical features of MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> disrupting <i>SLC16A2</i> and unfavorable nonrandom X-inactivation was reported [<a class="bk_pop" href="#thctd.REF.frints.2008.1029">Frints et al 2008</a>].</p><p>Although most of the psychomotor findings described above do not occur in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females, intellectual delay and intellectual disability have in rare instances been reported [<a class="bk_pop" href="#thctd.REF.dumitrescu.2004.168">Dumitrescu et al 2004</a>, <a class="bk_pop" href="#thctd.REF.schwartz.2005.41">Schwartz et al 2005</a>, <a class="bk_pop" href="#thctd.REF.herzovich.2007.1">Herzovich et al 2007</a>]. However, whether a causative relationship exists between <i>SLC16A2</i> pathogenic variants and cognitive impairments in heterozygous females has yet to be proven [<a class="bk_pop" href="#thctd.REF.schwartz.2005.41">Schwartz et al 2005</a>].</p></div><div id="thctd.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>A few pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (<a class="figpopup" href="/books/NBK26373/table/thctd.T.slc16a2_variants_discussed_in_th/?report=objectonly" target="object" rid-figpopup="figthctdTslc16a2variantsdiscussedinth" rid-ob="figobthctdTslc16a2variantsdiscussedinth">p.Ser194Phe</a>, <a class="figpopup" href="/books/NBK26373/table/thctd.T.slc16a2_variants_discussed_in_th/?report=objectonly" target="object" rid-figpopup="figthctdTslc16a2variantsdiscussedinth" rid-ob="figobthctdTslc16a2variantsdiscussedinth">p.Leu434Trp</a>, <a class="figpopup" href="/books/NBK26373/table/thctd.T.slc16a2_variants_discussed_in_th/?report=objectonly" target="object" rid-figpopup="figthctdTslc16a2variantsdiscussedinth" rid-ob="figobthctdTslc16a2variantsdiscussedinth">p.Leu492Pro</a>, <a class="figpopup" href="/books/NBK26373/table/thctd.T.slc16a2_variants_discussed_in_th/?report=objectonly" target="object" rid-figpopup="figthctdTslc16a2variantsdiscussedinth" rid-ob="figobthctdTslc16a2variantsdiscussedinth">p.Leu568Pro</a>) and the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of a single amino acid (<a class="figpopup" href="/books/NBK26373/table/thctd.T.slc16a2_variants_discussed_in_th/?report=objectonly" target="object" rid-figpopup="figthctdTslc16a2variantsdiscussedinth" rid-ob="figobthctdTslc16a2variantsdiscussedinth">p.Phe501del</a>) have been associated with milder psychomotor delays, including some speech development, some reading/writing, and/or the ability to walk without support despite ataxia [<a class="bk_pop" href="#thctd.REF.schwartz.2005.41">Schwartz et al 2005</a>, <a class="bk_pop" href="#thctd.REF.jansen.2008.2184">Jansen et al 2008</a>, <a class="bk_pop" href="#thctd.REF.visser.2009.29">Visser et al 2009</a>, <a class="bk_pop" href="#thctd.REF.visser.2013.310">Visser et al 2013</a>]. Independent walking and speech development are unusual in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males with other pathogenic variants.</p></div><div id="thctd.Penetrance"><h3>Penetrance</h3><p>No unaffected males with <i>SLC16A2</i> pathogenic variants have been reported; thus, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> appears to be 100%.</p><p>Heterozygous females are typically clinically normal.</p></div><div id="thctd.Anticipation"><h3>Anticipation</h3><p>Anticipation has not been observed.</p></div><div id="thctd.Nomenclature"><h3>Nomenclature</h3><p>MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency was given as a name of this condition, following the identification of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and the defect in thyroid hormone metabolism.</p><p>Because of the overlap between the clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in individuals with <i>SLC16A2</i> abnormalities and in those with a previously described syndrome, Allan-Herndon-Dudley syndrome (AHDS), <a class="bk_pop" href="#thctd.REF.schwartz.2005.41">Schwartz et al [2005]</a> analyzed <i>SLC16A2</i> in six families with AHDS. <i>SLC16A2</i> pathogenic variants were identified in all six; therefore, AHDS is now synonymous with MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency due to pathogenic variants in <i>SLC16A2</i>.</p></div><div id="thctd.Prevalence"><h3>Prevalence</h3><p>Prevalence of MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency remains unknown. However, the identification of more than 100 families in approximately ten years suggests that the syndrome is more common than previously expected.</p></div></div><div id="thctd.Genetically_Related_Allelic_Disord"><h2 id="_thctd_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><i>SLC16A2</i> pathogenic variants have been suspected as a cause of nonsyndromic <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> intellectual disability (i.e., without thyroid hormone abnormalities); however, one study that examined 401 male sibships with intellectual disability who had had no preliminary thyroid testing found an <i>SLC16A2</i> variant in only one family. Subsequent thyroid testing revealed that the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals did have the typical thyroid test results [<a class="bk_pop" href="#thctd.REF.frints.2008.1029">Frints et al 2008</a>].</p></div><div id="thctd.Differential_Diagnosis"><h2 id="_thctd_Differential_Diagnosis_">Differential Diagnosis</h2><p>Many disorders demonstrate hypotonia and severe intellectual disability in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance pattern. Several disorders, described below, also demonstrate spasticity, seizures, or other features that overlap with the neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the MCT8-specific thyroid hormone cell-membrane transporter deficiency and should be considered.</p><ul><li class="half_rhythm"><div class="half_rhythm"><a href="/books/n/gene/pmd/">Pelizaeus-Merzbacher disease</a> (PMD) and other <i>PLP1</i>-related disorders display a wide spectrum of phenotypes but can manifest in infancy or early childhood with nystagmus, hypotonia, and severe cognitive impairment and eventually progress to severe spasticity and ataxia. As with males with <i>SLC16A2</i> pathogenic variants, males with PMD present with delayed myelination during early childhood; however, they do not have the thyroid test abnormalities characteristic of MCT8-specific thyroid hormone cell-membrane transporter deficiency. <i>PLP1</i>-related disorders are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> pattern, and 80%-95% of males with a <i>PLP1</i>-related disorder have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PLP1</i>.</div><div class="half_rhythm">Of note, in one study <i>SLC16A2</i> pathogenic variants were reported in 11% of 53 families with a severe form of Pelizaeus-Merzbacher-like disease with an unusual improvement in myelination with age [<a class="bk_pop" href="#thctd.REF.vaursbarri_re.2009.114">Vaurs-Barri&#x000e8;re et al 2009</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Individuals with leukodystrophies, including <a href="/books/n/gene/mld/">metachromatic leukodystrophy</a> (arylsulfatase A deficiency), <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a>, <a href="/books/n/gene/krabbe/">Krabbe disease</a>, and <a href="/books/n/gene/canavan/">Canavan disease</a> have hypotonia, muscle wasting, and spasticity with no speech or ambulation. However, MRI, nerve conduction velocity (NCV) and evoked potentials are usually abnormal in these disorders.</div></li><li class="half_rhythm"><div class="half_rhythm">Males with <a href="/books/n/gene/mecp2-dup/"><i>MECP2</i> duplication syndrome</a> have infantile hypotonia, severe intellectual disability, absent speech, progressive spasticity, and seizures. Approximately 75% also have recurrent respiratory infections.</div></li></ul></div><div id="thctd.Management"><h2 id="_thctd_Management_">Management</h2><p>No current published guidelines exist to establish the extent of disease or proper management in an individual diagnosed with MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency. The following recommendations are based on current literature and the authors' experience.</p><div id="thctd.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the following are recommended:</p><ul><li class="half_rhythm"><div>Growth parameters</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Neurologic evaluation and EEG to assess possible seizures</div></li><li class="half_rhythm"><div>Orthopedic evaluation to assess for possible developing scoliosis or pectus deformities</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="thctd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following treatment is appropriate:</p><ul><li class="half_rhythm"><div>Physical, occupational, and speech therapies, if necessary</div></li><li class="half_rhythm"><div>Medications, such as anticholinergics, L-DOPA, carbamazepine, or lioresol, for the treatment of dystonia</div></li><li class="half_rhythm"><div>Glycopyrolate or scopolamine to improve drooling</div></li><li class="half_rhythm"><div>Standard anticonvulsant medication to control seizures, if present</div></li><li class="half_rhythm"><div>Placement of permanent feeding tube to avert malnutrition</div></li></ul><p>Note: Thyroid hormone treatment with replacement doses during childhood has no beneficial effect. However, combined treatment with high doses of levothyroxine (L-T<sub>4</sub>) and propylthiouracil (PTU), which inhibits deiodinase 1, has been shown to ameliorate the hypermetabolic state, with beneficial effects on body weight and heart rate, as seen in several <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#thctd.REF.w_meau.2008.2084">W&#x000e9;meau et al 2008</a>, <a class="bk_pop" href="#thctd.REF.visser.2013.310">Visser et al 2013</a>]. See also <a href="#thctd.Therapies_Under_Investigation">Therapies Under Investigation</a>.</p></div><div id="thctd.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Appropriate measures include the following:</p><ul><li class="half_rhythm"><div>Braces to prevent joint contractures and orthopedic surgery, if necessary</div></li><li class="half_rhythm"><div>Diet restrictions to prevent aspiration</div></li></ul></div><div id="thctd.Surveillance"><h3>Surveillance</h3><p>Appropriate surveillance includes the following:</p><ul><li class="half_rhythm"><div>Regular orthopedic evaluations to monitor scoliosis or joint problems</div></li><li class="half_rhythm"><div>Ongoing developmental assessments</div></li></ul></div><div id="thctd.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Aspiration of food should be avoided to prevent pneumonia.</p><p>Administration of L-T<sub>4</sub> or L-T<sub>3</sub> alone can exacerbate the high serum T<sub>3</sub> levels and the resulting hypermetabolism.</p></div><div id="thctd.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#thctd.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="thctd.Pregnancy_Management"><h3>Pregnancy Management</h3><p>In a recent report, two unaffected <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pregnant women with unaffected fetuses were treated with L-T<sub>4</sub> in the second half of pregnancy [<a class="bk_pop" href="#thctd.REF.ramos.2011.309">Ramos et al 2011</a>]. It is unclear if this had any effect, either beneficial or detrimental, on the fetus. Of note, many unaffected heterozygous mothers have given birth to normal unaffected children without any prenatal treatment.</p></div><div id="thctd.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Diiodothyropropionic acid (DITPA), a thyroid hormone analog that does not require MCT8 for transfer into cells, has been evaluated as a treatment in both a mouse model of Mct8 deficiency and in humans with MCT8-specific thyroid hormone cell-membrane transporter deficiency [<a class="bk_pop" href="#thctd.REF.di_cosmo.2009.4450">Di Cosmo et al 2009</a>, <a class="bk_pop" href="#thctd.REF.verge.2012.4515">Verge et al 2012</a>]. DITPA therapy was given to four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children with subsequent improvement in the hypermetabolic state; however, no significant neurologic improvement was obtained with this therapy. Consideration is being given to DITPA treatment during pregnancy, however such treatment has not been used to date, and there is no information on whether it will be effective.</p><p>Recently another analog TETRAC (3, 3', 5, 5'-tetraiodothyroacetic acid) has been tested in mice with Mct8 deficiency [<a class="bk_pop" href="#thctd.REF.horn.2013.968">Horn et al 2013</a>]. TETRAC treatment was able to promote TH-dependent neuronal differentiation in some brain areas but was ineffective in suppressing TRH (thyrotropin releasing hormone) in the hypothalamus. The efficacy of TETRAC therapy may vary among distinct neuronal populations or among different genes that are controlled by TH in a positive or negative manner. However, peripheral tissue thyrotoxicity in Mct8-deficient mice was not significantly ameliorated by TETRAC therapy.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="thctd.Genetic_Counseling"><h2 id="_thctd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="thctd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="thctd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disease nor will he be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a>.</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> analysis reveals that the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, the possible genetic explanations are:</div><ul><li class="half_rhythm"><div class="half_rhythm">The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. In this instance, the proband's mother does not have a pathogenic variant. <i>De novo</i> variants have been reported in MCT8-specific thyroid hormone cell-membrane transporter deficiency [Author, personal communication; <a class="bk_pop" href="#thctd.REF.dumitrescu.2004.168">Dumitrescu et al 2004</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s mother has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Either of the following two types of <i>de novo</i> pathogenic variants may be present in the mother:</div><ul><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/germline-variant/">germline variant</a> that was present at the time of her conception, is present in every cell of her body, and is detectable in her leukocytes;</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is present only in her ovaries (termed "<a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>") in which some germ cells have the variant and some do not, and in which the variant is not detectable in leukocyte DNA. Germline mosaicism has not been reported in MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency but has been observed in many <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorders and should be considered in the <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> of at-risk family members.</div></li></ul><div class="half_rhythm">In either of the preceding scenarios: all offspring of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s mother are at risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; sibs of the proband's mother are not at risk of inheriting the variant.</div></li><li class="half_rhythm"><div class="half_rhythm">The mother is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> and has inherited the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> either from her mother, in whom the variant was <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, or from her asymptomatic father, who has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for the variant.</div></li></ul></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an <i>SLC16A2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting the variant in each pregnancy is 50%. Males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the variant will be carriers and will usually not be affected but may have minor thyroid test abnormalities.</div></li><li class="half_rhythm"><div>If the family-specific <i>SLC16A2</i> sequence abnormality is not detected in the mother, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is much reduced, but greater than that of the general population. The risk depends on the probability of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent of the proband and the spontaneous mutation rate of <i>SLC16A2</i>. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males do not reproduce.</p><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected females may not reproduce; the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female reported had hypogonadotropic hypogonadism [<a class="bk_pop" href="#thctd.REF.frints.2008.1029">Frints et al 2008</a>]. Women carrying an <i>SLC16A2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the variant to each child: sons who inherit the pathogenic variant will be affected; daughters who inherit the variant will be carriers and may have minor thyroid test abnormalities.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> If the mother of the proband has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, her female relatives may be at risk of being carriers (typically asymptomatic, although they may have minor thyroid test abnormalities) and her male relatives may be at risk of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> depending on their genetic relationship to the proband. Phenotypically normal males are unlikely to carry the pathogenic variant.</p></div><div id="thctd.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Carrier testing of at-risk female relatives is possible if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the family.</p></div><div id="thctd.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="thctd.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="thctd.Resources"><h2 id="_thctd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>MCT8-AHDS Foundation</b></div><div>Canada</div><div><b>Email:</b> contact@mct8.info</div><div><a href="https://www.mct8.info/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mct8.info</a></div></li><li class="half_rhythm"><div><b>Una Vita Rara AHDS-MCT8 ONLUS (Italian AHDS-MCT8 Family Association)</b></div><div>Via Foina, 34</div><div>25040 Monticelli Brusati (BS) </div><div>Italy</div><div><b>Phone:</b> 39 329 0648896</div><div><b>Email:</b> unavitarara@gmail.com</div><div><a href="https://www.unavitarara.it/en/home-en/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.unavitarara.it</a></div></li><li class="half_rhythm"><div><b>American Association on Intellectual and Developmental Disabilities (AAIDD)</b></div><div>501 3rd Street Northwest</div><div>Suite 200</div><div>Washington DC 20001</div><div><b>Phone:</b> 202-387-1968</div><div><b>Fax:</b> 202-387-2193</div><div><b>Email:</b> sis@aaidd.org</div><div><a href="http://www.aaidd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aaidd.org</a></div></li><li class="half_rhythm"><div><b>Association Fran&#x000e7;aise Xtraordinaire</b></div><div>France</div><div><b>Phone:</b> 09 70 40 61 40</div><div><b>Email:</b> contact@xtraordinaire.org</div><div><a href="http://xtraordinaire.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.xtraordinaire.org</a></div></li><li class="half_rhythm"><div><b>EURORDIS-Rare Diseases Europe</b></div><div><i>The Voice of Rare Disease Patients in Europe</i></div><div>The Voice of Rare Disease Patients in Europe</div><div>Plateforme Maladies Rares</div><div>96, rue Didot</div><div>Paris 75014 </div><div>France</div><div><b>Phone:</b> 33 1 56 53 52 10</div><div><b>Fax:</b> 33 1 56 53 52 15</div><div><b>Email:</b> eurordis@eurordis.org</div><div><a href="https://www.eurordis.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.eurordis.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001523.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>National Center on Birth Defects and Developmental Disabilities</b></div><div>1600 Clifton Road</div><div>MS E-87</div><div>Atlanta GA 30333</div><div><b>Phone:</b> 800-232-4636 (toll-free); 888-232-6348 (TTY)</div><div><b>Email:</b> cdcinfo@cdc.gov</div><div><a href="http://www.cdc.gov/ncbddd/dd/ddmr.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li></ul></div><div id="thctd.Molecular_Genetics"><h2 id="_thctd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="thctd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK26373/table/thctd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__thctd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_thctd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_thctd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_thctd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_thctd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_thctd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_thctd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_thctd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6567" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC16A2</i></a></td><td headers="hd_b_thctd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6567" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq13<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_thctd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P36021" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Monocarboxylate transporter 8</a></td><td headers="hd_b_thctd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/SLC16A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC16A2 @ LOVD</a></td><td headers="hd_b_thctd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC16A2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC16A2</a></td><td headers="hd_b_thctd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC16A2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC16A2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="thctd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="thctd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency (<a href="/omim/300095,300523" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK26373/table/thctd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__thctd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300095" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300095</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 2; SLC16A2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300523" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300523</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ALLAN-HERNDON-DUDLEY SYNDROME; AHDS</td></tr></tbody></table></div></div><div id="thctd.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Monocarboxylate transporter 8 (MCT8) the protein product of <i>SLC16A2</i>, is thought to play a role in neuronal T<sub>3</sub> uptake and in endothelial cells allowing partial entry of thyroid hormone through the blood-brain barrier. MCT8 deficiency results in an insufficient supply of T<sub>3</sub> to nuclear T<sub>3</sub> receptors. Thyroid hormone plays a crucial role in brain development. Thus, it is presumed that the decreased access of T<sub>3</sub> to brain cells can lead to the severe defects in neurologic development seen in males with MCT8<i>-</i>specific thyroid hormone cell-membrane transporter deficiency [<a class="bk_pop" href="#thctd.REF.friesema.2006.512">Friesema et al 2006</a>, <a class="bk_pop" href="#thctd.REF.roberts.2008.6251">Roberts et al 2008</a>, <a class="bk_pop" href="#thctd.REF.ceballos.2009.2491">Ceballos et al 2009</a>].</p><p><b>Gene structure.</b>
<i>SLC16A2</i> consists of six coding exons. It has two translation start sites (see <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>). For a detailed summary of gene and protein information, see <a href="/books/NBK26373/#thctd.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> The only reported nonsynonymous variant is c.319T&#x0003e;C (p.Ser107Pro) in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1; two independent studies have confirmed a lack of association between this variant and either serum thyroid hormone levels or <i>SLC16A2</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> levels [<a class="bk_pop" href="#thctd.REF.lagolest_n.2009.636">Lago-Lest&#x000f3;n et al 2009</a>, <a class="bk_pop" href="#thctd.REF.van_der_deure.2010.1">van der Deure et al 2010</a>]. The synonymous <a class="def" href="/books/n/gene/glossary/def-item/benign-variant/">benign variant</a> c.1095A&#x0003e;T in exon 3 has a frequency of 3.3% in the African American population. Several synonymous variants have been recently reported but their frequencies are not known [<a class="bk_pop" href="#thctd.REF.frints.2008.1029">Frints et al 2008</a>, <a class="bk_pop" href="#thctd.REF.visser.2013.310">Visser et al 2013</a>].</p><p><b>Pathogenic variants.</b> More than 70 variants have been identified in <i>SLC16A2</i>. Reported variants are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. They include full-gene and intragenic deletions and frameshift, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a>, and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. Functional studies have confirmed the pathogenesis of many of the missense variants. A particularly interesting variant, c.1834delC, results in bypassing the natural stop codon, extending the MCT8 protein by 65 amino acids and probably adding a thirteenth transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#thctd.REF.maranduba.2006.457">Maranduba et al 2006</a>].</p><div id="thctd.T.slc16a2_variants_discussed_in_th" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>SLC16A2</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK26373/table/thctd.T.slc16a2_variants_discussed_in_th/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__thctd.T.slc16a2_variants_discussed_in_th_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Benign</b></td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.319T&#x0003e;C<br /><a href="/SNP/snp_ref.cgi?searchType=adhoc_search&#x00026;type=rs&#x00026;rs=rs6647476" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs6647476</a>&#x000a0;<sup>2</sup></td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser107Pro</td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_4" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/164663748" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006517<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/5730045" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006508<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1095A&#x0003e;T<br /><a href="/SNP/snp_ref.cgi?searchType=adhoc_search&#x00026;type=rs&#x00026;rs=rs12849161" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs12849161</a>&#x000a0;<sup>2</sup></td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(=)&#x000a0;<sup>3</sup><br />(p.Pro365Pro)</td></tr><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.581C&#x0003e;T</td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser194Phe</td></tr><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1301T&#x0003e;G</td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu434Trp</td></tr><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1475T&#x0003e;C</td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu492Pro</td></tr><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1501_1503del<br />(1497_1499delCTT)</td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe501del</td></tr><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1703T&#x0003e;C</td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu568Pro</td></tr><tr><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1835delC<br />(1834delC)</td><td headers="hd_h_thctd.T.slc16a2_variants_discussed_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro612GlnfsTer68<br />(Pro612fsTer679)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="thctd.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="thctd.TF.2.2"><p class="no_margin">Reference SNP</p></div></dd><dt>3. </dt><dd><div id="thctd.TF.2.3"><p class="no_margin">p.(=) designates that protein has not been analyzed, but no change is expected</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC16A2</i> has two translation start sites, which generate proteins of either 613 amino acids or 539 (<a href="/protein/NP_006508.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006508.2</a>) amino acids. Both of these MCT8 proteins contain 12 putative transmembrane domains.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> MCT8-specific thyroid hormone cell-membrane transporter deficiency results from a loss of function of the MCT8 protein. Most pathogenic variants cause decreased activity or complete inactivation of the MCT8 transporter [<a class="bk_pop" href="#thctd.REF.friesema.2006.512">Friesema et al 2006</a>]. This leads to a decrease in thyroid hormone uptake into neurons, which is presumably the cause of the neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Other as-yet unknown mechanisms cannot be excluded.</p></div></div><div id="thctd.References"><h2 id="_thctd_References_">References</h2><div id="thctd.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.brockmann.2005.663">Brockmann K, Dumitrescu AM, Best TT, Hanefeld F, Refetoff S. X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene. <span><span class="ref-journal">J Neurol. </span>2005;<span class="ref-vol">252</span>:663–6.</span> [<a href="/pubmed/15834651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15834651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.ceballos.2009.2491">Ceballos A, Belinchon MM, Sanchez-Mendoza E, Grijota-Martinez C, Dumitrescu AM, Refetoff S, Morte B, Bernal J. Importance of monocarboxylate transporter 8 (Mct8) for the blood-brain barrier dependent availability of 3,5,3'-triiodo-L-thyronine (T3). <span><span class="ref-journal">Endocrinology. </span>2009;<span class="ref-vol">150</span>:2491–6.</span> [<a href="/pmc/articles/PMC2671898/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2671898</span></a>] [<a href="/pubmed/19147674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19147674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.di_cosmo.2009.4450">Di Cosmo C, Liao XH, Dumitrescu AM, Weiss RE, Refetoff S. A thyroid hormone analogue with reduced dependence on the monocarboxylate transporter 8 (MCT8) for tissue transport. <span><span class="ref-journal">Endocrinology. </span>2009;<span class="ref-vol">150</span>:4450–8.</span> [<a href="/pmc/articles/PMC2736078/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2736078</span></a>] [<a href="/pubmed/19497976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19497976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.dumitrescu.2004.168">Dumitrescu AM, Liao X-H, Best TD, Brockmann K, Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:168–75.</span> [<a href="/pmc/articles/PMC1181904/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181904</span></a>] [<a href="/pubmed/14661163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14661163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.dumitrescu.2009">Dumitrescu AM, Refetoff S. Cell transport defects. In: Wondisford FE, Radovick S, eds. <em>Clinical Management of Thyroid Disease</em>. Chap 22. Philadelphia, PA: Elsevier Saunders; 2009:317-23.</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.visser.2013.310">Visser WE, Vrijmoeth P, Visser FE, Arts WF, van Toor H, Visser TJ. Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2013;<span class="ref-vol">78</span>:310–5.</span> [<a href="/pubmed/22924588" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22924588</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.friesema.2006.512">Friesema ECH, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ. Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. <span><span class="ref-journal">Nat Clin Pract Endocrinol Metab. </span>2006;<span class="ref-vol">2</span>:512–23.</span> [<a href="/pubmed/16957765" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16957765</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.frints.2008.1029">Frints SGM, Lenzner S, Bauters M, Jensen LR, Esch HV, des Portes V, Moog U, Macville MVE, van Roozendaal K, Schrander-Stumpel CTRM, Tzschach A, Marynen P, Fryns J, Hamel B, van Bokhoven H, Chelly J, Beldjord C, Turner G, Gecz J, Moraine C, Raynaud M, Ropers HH, Froyen G, Kuss AW. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:1029–37.</span> [<a href="/pubmed/18398436" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18398436</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.fuchs.2009.240">Fuchs O, Pfarr N, Pohlenz J, Schmidt H. Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutation. <span><span class="ref-journal">Dev Med Child Neurol. </span>2009;<span class="ref-vol">51</span>:240–4.</span> [<a href="/pubmed/19018842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19018842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.gika.2010.475">Gika AD, Siddiqui A, Hulse AJ, Edward S, Fallon P, McEntagart ME, Jan W, Josifova D, Lerman-Sagie T, Drummond J, Thompson E, Refetoff S, B&#x000f6;nnemann CG, Jungbluth H. White matter abnormalities and dystonic motor disorder associated with mutations in the SLC16A2 gene. <span><span class="ref-journal">Dev Med Child Neurol. </span>2010;<span class="ref-vol">52</span>:475–82.</span> [<a href="/pmc/articles/PMC5800746/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5800746</span></a>] [<a href="/pubmed/19811520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19811520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.herzovich.2007.1">Herzovich V, Vaiani E, Marino R, Dratler G, Lazzati JM, Tilitzky S, Ramirez P, Iorcansky S, Rivarola MA, Belgorosky A. Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene. <span><span class="ref-journal">Horm Res. </span>2007;<span class="ref-vol">67</span>:1–6.</span> [<a href="/pubmed/16974106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16974106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.holden.2005.852">Holden KR, Zu&#x000f1;iga OF, May MM, Su H, Molinero MR, Rogers RC, Schwartz CE. X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype. <span><span class="ref-journal">J Child Neurol. </span>2005;<span class="ref-vol">20</span>:852–7.</span> [<a href="/pubmed/16417886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16417886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.horn.2013.968">Horn S, Kersseboom S, Mayerl S, M&#x000fc;ller J, Groba C, Trajkovic-Arsic M, et al.  Tetrac Can Replace Thyroid Hormone During Brain Development in Mouse Mutants Deficient in the Thyroid Hormone Transporter Mct8. <span><span class="ref-journal">Endocrinology. </span>2013;<span class="ref-vol">154</span>:968–79.</span> [<a href="/pubmed/23307789" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23307789</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.jansen.2008.2184">Jansen J, Friesema EC, Kester MH, Schwartz CE, Visser TJ. Genotype-phenotype relationship in patients with mutations in thyroid hormone transporter MCT8. <span><span class="ref-journal">Endocrinology. </span>2008;<span class="ref-vol">149</span>:2184–90.</span> [<a href="/pmc/articles/PMC2734492/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2734492</span></a>] [<a href="/pubmed/18187543" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18187543</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.kakinuma.2005.552">Kakinuma H, Itoh M, Takahashi H. A novel mutation in the monocarboxylate transporter 8 gene in a boy with putamen lesions and low free T4 levels in cerebrospinal fluid. <span><span class="ref-journal">J Pediatr. </span>2005;<span class="ref-vol">147</span>:552–4.</span> [<a href="/pubmed/16227048" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16227048</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.lagolest_n.2009.636">Lago-Lest&#x000f3;n R, Iglesias MJ, San-Jos&#x000e9; E, Areal C, Eiras A, Ara&#x000fa;jo-Vilar D, Lado-Abeal J, Dom&#x000ed;nguez-Gerpe L. Prevalence and functional analysis of the S107P polymorphism (rs6647476) of the monocarboxylate transporter 8 (SLC16A2) gene in the male population of north-west Spain (Galicia). <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2009;<span class="ref-vol">70</span>:636–43.</span> [<a href="/pubmed/18710470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18710470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.maranduba.2006.457">Maranduba CM, Friesema EC, Kok F, Kester MH, Jansen J, Serti&#x000e9; AL, Passos-Bueno MR, Visser TJ. Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:457–60.</span> [<a href="/pmc/articles/PMC2649011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2649011</span></a>] [<a href="/pubmed/15980113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15980113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.ramos.2011.309">Ramos HE, Morandini M, Carre A, Tron E, Floch C, Mandelbrot L, et al.  Pregnancy in women heterozygous for MCT8 mutations: risk of maternal hypothyroxinemia and fetal care. <span><span class="ref-journal">Eur J Endocrinol. </span>2011;<span class="ref-vol">164</span>:309–14.</span> [<a href="/pubmed/21098685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21098685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.refetoff.2007.277">Refetoff S, Dumitrescu AM. Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. <span><span class="ref-journal">Best Pract Res Clin Endocrinol Metab. </span>2007;<span class="ref-vol">21</span>:277–305.</span> [<a href="/pubmed/17574009" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17574009</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.roberts.2008.6251">Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N. Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier. <span><span class="ref-journal">Endocrinology. </span>2008;<span class="ref-vol">149</span>:6251–61.</span> [<a href="/pubmed/18687783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18687783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.schwartz.2005.41">Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ, Stevenson RE. Allan-Herndon-Dudley syndrome and the MCT8 thyroid hormone transporter. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:41–53.</span> [<a href="/pmc/articles/PMC1226193/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1226193</span></a>] [<a href="/pubmed/15889350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15889350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.schwartz.2007.307">Schwartz CE, Stevenson RE. The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. <span><span class="ref-journal">Best Pract Res Clin Endocrinol Metab. </span>2007;<span class="ref-vol">21</span>:307–21.</span> [<a href="/pmc/articles/PMC2094733/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2094733</span></a>] [<a href="/pubmed/17574010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17574010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.sijens.2008.1854">Sijens PE, R&#x000f6;diger LA, Meiners LC, Lunsing RJ. 1H magnetic resonance spectroscopy in monocarboxylate transporter 8 gene deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2008;<span class="ref-vol">93</span>:1854–9.</span> [<a href="/pubmed/18319316" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18319316</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.tonduti.2013.795">Tonduti D, Vanderver A, Berardinelli A, Schmidt JL, Collins CD, Novara F, Di Genni A, Mita A, Triulzi F, Brunstrom-Hernandez JE, Zuffardi O, Balottin U, Orcesi S. MCT8 deficiency: extrapyramidal symptoms and delayed myelination as prominent features. <span><span class="ref-journal">J Child Neurol. </span>2013;<span class="ref-vol">28</span>:795–800.</span> [<a href="/pmc/articles/PMC4155008/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4155008</span></a>] [<a href="/pubmed/22805248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22805248</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.tsurusaki.2011.606">Tsurusaki Y, Osaka H, Hamanoue H, Shimbo H, Tsuji M, Doi H, Saitsu H, Matsumoto N, Miyake N. Rapid detection of a mutation causing X-linked leucoencephalopathy by exome sequencing. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:606–9.</span> [<a href="/pubmed/21415082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21415082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.van_der_deure.2010.1">van der Deure WM, Peeters RP, Visser TJ. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10 and OATPs, and the effects of genetic variation in these transporters. <span><span class="ref-journal">J Mol Endocrinol. </span>2010;<span class="ref-vol">44</span>:1–11.</span> [<a href="/pubmed/19541799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19541799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.vaursbarri_re.2009.114">Vaurs-Barri&#x000e8;re C, Deville M, Sarret C, Giraud G, Des Portes V, Prats-Vinas JM, De Michele G, Dan B, Brady AF, Boespflug-Tanguy O, Touraine R. Pelizaeus-Merzbacher-like disease presentation of MCT8 mutated male subjects. <span><span class="ref-journal">Ann Neurol. </span>2009;<span class="ref-vol">65</span>:114–18.</span> [<a href="/pubmed/19194886" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19194886</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.verge.2012.4515">Verge CF, Konrad D, Cohen M, Di Cosmo C, Dumitrescu AM, Marcinkowski T, et al.  Diiodothyropropionic Acid (DITPA) in the Treatment of MCT8 Deficiency. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:4515–23.</span> [<a href="/pmc/articles/PMC3513545/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3513545</span></a>] [<a href="/pubmed/22993035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22993035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.visser.2009.29">Visser WE, Jansen J, Friesema EC, Kester MH, Mancilla E, Lundgren J, van der Knaap MS, Lunsing RJ, Brouwer OF, Visser TJ. Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations. <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:29–38.</span> [<a href="/pubmed/18636565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18636565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="thctd.REF.w_meau.2008.2084">W&#x000e9;meau JL, Pigeyre M, Proust-Lemoine E, d'Herbomez M, Gottrand F, Jansen J, Visser TJ, Ladsous M. Beneficial effects of propylthiouracil plus L-thyroxine treatment in a patient with a mutation in MCT8. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2008;<span class="ref-vol">93</span>:2084–8.</span> [<a href="/pubmed/18334584" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18334584</span></a>]</div></li></ul></div></div><div id="thctd.Chapter_Notes"><h2 id="_thctd_Chapter_Notes_">Chapter Notes</h2><div id="thctd.Acknowledgments"><h3>Acknowledgments</h3><p>Drs Dumitrescu and Refetoff are supported in part by grants DR15070, DK07011, RR04999 and DK091016 from the National Institutes of Health. Dr Fu is funded by an award from China Scholarship Council.</p></div><div id="thctd.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 April 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>9 March 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>6 July 2009 (mad) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK26373</span><span class="label">PMID: <a href="/pubmed/20301789" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301789</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mbd5-dis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rett/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK26373&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK26373/?report=reader">PubReader</a></li><li><a href="/books/NBK26373/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK26373" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK26373" style="display:none" title="Cite this Page"><div class="bk_tt">Dumitrescu AM, Fu J, Dempsey MA, et al. MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency. 2010 Mar 9 [Updated 2013 Apr 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK26373/pdf/Bookshelf_NBK26373.pdf">PDF version of this page</a> (476K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#thctd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#thctd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#thctd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#thctd.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#thctd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#thctd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#thctd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#thctd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#thctd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#thctd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#thctd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6567[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC16A2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK26373+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1952986" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1952986" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1952986" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1952986" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30392207" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].</a><span class="source">[Zhonghua Er Ke Za Zhi. 2018]</span><div class="brieflinkpop offscreen_noflow">[A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tang YL, Peng J, Xiong J, Pang N, Wu LW, Yang HY, Kessi M, Yin F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Zhonghua Er Ke Za Zhi. 2018 Nov 2; 56(11):829-834. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20713192" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH.</a><span class="source">[Eur J Med Genet. 2010]</span><div class="brieflinkpop offscreen_noflow">Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Boccone L, Mariotti S, Dessì V, Pruna D, Meloni A, Loudianos G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Eur J Med Genet. 2010 Nov-Dec; 53(6):392-5. Epub 2010 Aug 14.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301503" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Disorders of Intracellular Cobalamin Metabolism<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sloan JL, Carrillo N, Adams D, Venditti CP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301298" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Darras BT, Urion DK, Ghosh PS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301789" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301789" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041791dd21425a25300a56">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency - GeneReviews...</a><div class="ralinkpop offscreen_noflow">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:14:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88122CE04105A100000000034A0147&amp;ncbi_session=CE88122CE0417911_0842SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK26373%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK26373&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK26373/&amp;ncbi_pagename=MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88122CE0417911_0842SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>